[Corrigendum] A Germline Alteration of ERBB2 Increases the Risk of Breast Cancer in Chinese Han Women with a Familial History of Malignant Tumors

Yan Ju,Lifeng Wang,Shengjun Ta,Rui Shu,Shanling Yang,Xican Gao,Hongping Song,Liwen Liu

DOI: https://doi.org/10.3892/ol.2019.10930

2019-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2019.10646.].

What problem does this paper attempt to address?

Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients (vol 11, 655709, 2021)

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Correction: the Hmlh1 −93g>a Polymorphism and Risk of Ovarian Cancer in the Chinese Population

Leilei Niu,Shumin Li,Huamao Liang,Hua Li

DOI: https://doi.org/10.1371/journal.pone.0218032

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0135822.].
Corrigendum: Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire

Kai Gao,Lingyan Chen,Yuanwei Zhang,Yi Zhao,Ziyun Wan,Jinghua Wu,Liya Lin,Yashu Kuang,Jinhua Lu,Xiuqing Zhang,Lei Tian,Xiao Liu,Xiu Qiu

DOI: https://doi.org/10.3389/fimmu.2020.01752

IF: 7.3

2020-08-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.02064.].

immunology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Yue-chen Xu,Jian-xiong Wang,Yi-ran Chu,Han Qian,Hong-yan Wang,Fan Wang

DOI: https://doi.org/10.3389/fonc.2023.1254132

IF: 4.7

2023-07-28

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1170119.].

oncology
Corrigendum: Genome-wide Association Study of Esophageal Squamous Cell Carcinoma in Chinese Subjects Identifies Susceptibility Loci at PLCE1 and C20orf54

Lidong Wang,Fuyou Zhou,Xuemin Li,Liangdan Sun,Xin Song,Yan Jin,LI Jiang-man,Guo-Qiang Kong,Hong Qi,Juan Cui,Lian-Qun Zhang,Jiezhi Yang,Jilin Li,Xing-Chuan Li,Jingli Ren,Zhicai Liu,Wenjun Gao,Ling Yuan,Wei Wu,Yanrui Zhang,Weipeng Wang,Ilyar Sheyhidin,Feng Li,Bao-Ping Chen,Shu‐Wei Ren,Bin Liu,Dan Li,Jian-Wei Ku,Zong-Min Fan,Shengli Zhou,Zhigang Guo,Xueke Zhao,Na Liu,Yong-hong Ai,Fang‐Fang Shen,Wenyan Cui,Shuang Song,Tao Guo,Jing Huang,Chao Yuan,Jia Huang,WU Yi-ming,Wenbin Yue,Feng Chen,Honglei Li,Yan Wang,Jin-Ya Tian,Yao Lu,Yi Yuan,Wenliang Zhu,Min Liu,Wenjing Fu,Yang Xia,Han-Jing Wang,Suo-Li Han,Jie Chen,Han Miao,Haiyan Wang,Peng Zhang,Xiumin Li,Jin-Cheng Dong,Guo-Lan Xing,Ran Wang,Ming Guo,Zhiwei Chang,Hailin Liu,Li Guo,Zhiqing Yuan,Hai Liu,Qiumin Lu,Liu-Qin Yang,Fu-Guo Zhu,Xiufeng Yang,Xiaoshan Feng,Zhou Wang,Li Yin,Shegan Gao,Qirenwang Qige,Long-Tang Bai,Wenjun Yang,Guangyan Lei,Zhong‐Ying Shen,Long-Qi Chen,En‐Min Li,Li Xu,Zhiyong Wu,Wei-Ke Cao,Jianpo Wang,Zhi-Qin Bao,Ji‐Li Chen,Guang-Cheng Ding,Xiang Zhuang,Yingfa Zhou,Hou‐Feng Zheng,Zheng Zhang,Xianbo Zuo,Ziming Dong,Daiming Fan,Xin He,Jin Wang,Qi Zhou,Qinxian Zhang,Xin-Ying Jiao,Sen Lian,Ai-Fang Ji,Xiaomei Lü,Jinsheng Wang,Fu-Bao Chang,Lu Chen,Zhiguo Chen,Jianjun Miao,Fan Zhang,Ruobai Lin,Tai-Jiang Liu,Jin-Chang Wei,Qing‐Peng Kong,Yu-Ching Lan,Yu-Jing Fan,Fusheng Gao,Tianyun Wang,Dong Xie,Shuqing Chen,Wancai Yang,Jun‐Yan Hong,Liang Wang,Song-Liang Qiu,Zhiming Cai,Xuejun Zhang

DOI: https://doi.org/10.1038/ng0914-1041

IF: 30.8

2014-01-01

Nature Genetics

Abstract:Nat. Genet. 42, 759–763 (2010); published online 22 August 2010; corrected after print 27 August 2014 In contrast to the version of this article initially published, the authors now find no evidence to support association with esophageal squamous cell carcinoma susceptibility for rs13042395[T] at 20p13 in their original data, in two independent sets of cases and controls collected in other Chinese populations or in the joint analysis of these three studies.
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
The Hmlh1 -93g > A Polymorphism And Risk Of Ovarian Cancer In The Chinese Population (Vol 10, E0135822, 2015)

Leilei Niu,Shumin Li,Huamao Liang,Hua Li

DOI: https://doi.org/10.1371/journal.pone.0218032

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0135822.].
Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Tao Wang,Tianye Li,Baiqing Li,Jiahui Zhao,Zhi Li,Mingyi Sun,Yan Li,Yanjiao Zhao,Shidi Zhao,Weiguang He,Xiao Guo,Rongjing Ge,Lian Wang,Dushan Ding,Saisai Liu,Simin Min,Xiaonan Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1134847

IF: 7.3

2023-01-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

immunology
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Bin Ma,Wenjia Guo,Meihui Shan,Nan Zhang,Binlin Ma,Gang Sun

DOI: https://doi.org/10.1515/biol-2022-0810

2023-12-16

Abstract:[This corrects the article DOI: 10.1515/biol-2020-0054.].
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Correction: Corrigendum: Genome-wide Association Study Identifies New Susceptibility Loci for Epithelial Ovarian Cancer in Han Chinese Women

Chen, Kexin,Ma, Hongxia,Li, Lian,Zang, Rongyu,Wang, Cheng,Song, Fengju,Shi, Tingyan,Yu, Dianke,Yang, Ming,Xue, Wenqiong,Dai, Juncheng,Li, Shuang,Zheng, Hong,Wu, Chen,Zhang, Ying,Wu, Xiaohua,Li, Dake,Xue, Fengxia,Li, Haixin,Jiang, Zhi,Liu, Jibin,Liu, Yuexin,Li, Pei,Tan, Wen,Han, Jing,Jie, Jiang,Hao, Quan,Hu, Zhibin,Lin, Dongxin,Ma, Ding,Jia, Weihua,Shen, Hongbing,Wei, Qingyi

DOI: https://doi.org/10.1038/ncomms6828

IF: 16.6

2014-01-01

Nature Communications

Abstract:Nature Communications 5: Article number: 4682 (2014); Published: 19 August 2014; Updated: 17 December 2014. The original version of the Supplementary Information attached to this Article contained an error in the numbering of the Supplementary Tables. The HTML has now been updated to include a corrected version of the Supplementary Information.
Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Jia Yao,Shengwei Li,Xiaosheng Wang

DOI: https://doi.org/10.3389/fcell.2022.948644

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.781848.].
Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Jinguo Zhang,Benjie Shan,Lin Lin,Jie Dong,Qingqing Sun,Qiong Zhou,Jian Chen,Xinghua Han

DOI: https://doi.org/10.3389/fcell.2021.812770

IF: 5.5

2021-12-09

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.711859.].

cell biology,developmental biology
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357

Hui Shi,Luping Zhao,Xinlin Guo,Runping Fang,Hui Zhang,Guanjun Dong,Jia Fu,Fenglian Yan,Junfeng Zhang,Zhaochen Ning,Qun Ma,Zhihua Li,Chunxia Li,Jun Dai,Chuanping Si,Huabao Xiong

DOI: https://doi.org/10.3390/ijms21228850

IF: 5.6

2020-11-23

International Journal of Molecular Sciences

Abstract:The authors wish to make the following correction to this paper [...]

biochemistry & molecular biology,chemistry, multidisciplinary
[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

Ying Liu,Wenfeng Yu,Peng Ren,Ting Zhang

DOI: https://doi.org/10.3892/mmr.2024.13186

IF: 3.423

2024-02-22

Molecular Medicine Reports

Abstract:Subsequently to the publication of this paper, the authors' have realized that Fig. 2A on p. 3927 was published featuring an error; specifically, there was an unintentional duplication of one of the representative images chosen for the figure (the same image was selected to represent the 'BRCA/Normal' and 'Tumor/LUSC' experiments). Additionally, the sample numbers in Fig. 2A were also incorrect. The correct sample numbers are as follows: 3 samples of breast tissue, 12 samples of breast cancer tissue, 3 samples of normal cervical tissue, 9 samples of CESC, 7 samples of LIHC, 3 samples of normal lung tissue and 6 samples of LUSC. These errors were due to negligence during the storage of HPA database images. The revised version of Fig. 2, showing the correct data for the 'Tumor/LUSC' experiment in Fig. 2A (where the error occurred), is shown on the next page. Note that this error did not significantly affect either the results or the conclusions reported in this paper, and all the authors agree to the corrigendum. The authors do stress the importance of a larger sample size to ascertain statistically significant differences in CENPM protein expression, predominantly localized in the cell nucleus. Furthermore, the authors thank the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 22: 3922‐3934, 2020; DOI: 10.3892/mmr.2020.11461]

oncology,medicine, research & experimental
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].

[Corrigendum] A Germline Alteration of ERBB2 Increases the Risk of Breast Cancer in Chinese Han Women with a Familial History of Malignant Tumors

Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients (vol <i>11</i>, <i>655709</i>, <i>2021</i>)

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Correction: the Hmlh1 −93g&gt;a Polymorphism and Risk of Ovarian Cancer in the Chinese Population

Corrigendum: Germline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Diseases of the musculoskeletal system and connective tissue and risk of breast cancer: mendelian randomization study in European and East Asian populations

Corrigendum: Genome-wide Association Study of Esophageal Squamous Cell Carcinoma in Chinese Subjects Identifies Susceptibility Loci at PLCE1 and C20orf54

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

The Hmlh1 -93g > A Polymorphism And Risk Of Ovarian Cancer In The Chinese Population (Vol 10, E0135822, 2015)

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Correction: Corrigendum: Genome-wide Association Study Identifies New Susceptibility Loci for Epithelial Ovarian Cancer in Han Chinese Women

Corrigendum: Identification of Breast Cancer Immune Subtypes by Analyzing Bulk Tumor and Single Cell Transcriptomes

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357

[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Correction: the Hmlh1 −93g>a Polymorphism and Risk of Ovarian Cancer in the Chinese Population